Stocks Health care STAA
NASDAQ · Health careStaar Surgical Co (STAA)
Staar Surgical Co brought in $339.6M of revenue over the twelve months to July 3, 2026, up 51.3% from a year earlier. Net income was $3.8M, a net margin of 1.1%. In fiscal 2025 capital spending exceeded operating cash flow by $40.1M. At July 3, 2026 it held $148.6M in cash. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on August 12, 2026.
What Staar Surgical Co does
Staar Surgical Co is registered with the SEC under industry code SIC 3851 (Ophthalmic Goods). Its shares trade on NASDAQ under the ticker STAA.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2025 | $239.4M | -$80.4M | -$1.62 | -$40.1M |
| 2024 | $313.9M | -$20.2M | -$0.41 | -$7.7M |
| 2023 | $322.4M | $21.3M | $0.43 | -$3.6M |
| 2022 | $239.4M | $39.7M | $0.80 | $17.6M |
| 2021 | $230.5M | $27.5M | $0.56 | $30.3M |
| 2020 | $163.5M | $5.9M | $0.13 | $12.5M |
Latest SEC filings
What Staar Surgical Co has filed recently, newest first. Each links to the original document on SEC EDGAR.
- September 10, 2026
- August 14, 2026Passive stake changed SCHEDULE 13G/A
- August 12, 2026Quarterly report 10-Q · period to July 3, 2026
- August 12, 2026
- August 6, 2026
- June 24, 2026
- June 22, 2026
- June 9, 2026
- May 13, 2026Quarterly report 10-Q · period to April 3, 2026
- May 13, 2026
Questions about STAA
What does Staar Surgical Co do?
Staar Surgical Co is registered with the SEC under industry code SIC 3851 (Ophthalmic Goods). Its shares trade on NASDAQ under the ticker STAA.
Is Staar Surgical Co profitable?
Yes. Over the twelve months to July 3, 2026 it reported net income of $3.8M on revenue of $339.6M, a net margin of 1.1%.
How much revenue does Staar Surgical Co make?
Over the twelve months to July 3, 2026 Staar Surgical Co reported revenue of $339.6M. That is 51.3% more than a year earlier.
When did Staar Surgical Co last report?
Its most recent periodic report is the quarterly report (10-Q) filed on August 12, 2026. It covers the period to July 3, 2026. Its newest filing of any kind is the executive or director change from September 10, 2026.
Similar companies
Follow STAA
Get an email when Staar Surgical Co files with the SEC: results, executive changes, material agreements and annual reports.
Follow STAA: get an email when it filesWhere the numbers come from
Financial figures are the values Staar Surgical Co tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.